Molecules with antibody combining sites that bind to hydrolytic

Drug – bio-affecting and body treating compositions – Lymphokine

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

436547, 549220, 549289, 548462, 548465, 548415, 435814, 435 19, 435196, 558193, A61K 3900, C07F 940, C07F 965, C07D20948

Patent

active

046595678

ABSTRACT:
A phosphonamidate or phosphonate analog-ligand having a conformation that substantially corresponds to the conformation of a hydrolytic transition state of an amide or ester ligand is used to produce antibodies of predetermined specificity. The antibodies include an epitope that binds to and thereby stabilizes the tetrahedral carbon atom of the amide or ester hydrolysis transition state of the ligand to hydrolyze the ligand at a predetermined site.

REFERENCES:
patent: 3641147 (1972-02-01), Taplias
patent: 3733379 (1973-05-01), Szabo
patent: 3876666 (1975-04-01), Oswald et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Molecules with antibody combining sites that bind to hydrolytic does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Molecules with antibody combining sites that bind to hydrolytic , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Molecules with antibody combining sites that bind to hydrolytic will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-750775

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.